Report #2890461

Received Mar 23, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: 68 yrs
State: FL
Recovered: Unknown
Vaccinated: Mar 13, 2026
Onset: Mar 13, 2026
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (NO BRAND NAME)	UNKNOWN MANUFACTURER	3	4A4BM	—

Symptoms (1)

Extra dose administered

Symptom narrative

3rd dose administered; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of extra dose administered in a 68-year-old male patient who received Herpes zoster (Shingles vaccine) (batch number 4A4BM, expiry date 18-MAR-2027) for prophylaxis. Previously administered products included Shingrix (first dose received on 27-JUN-2021) and Shingrix (second dose received on 01-SEP-2021). On 13-MAR-2026, the patient received the 3rd dose of Shingles vaccine. On 13-MAR-2026, an unknown time after receiving Shingles vaccine, the patient experienced extra dose administered (Verbatim: 3rd dose administered). Additional Information: GSK Receipt Date: 13-MAR-2026 The reporter mentioned that the patient was administered with 3rd dose as it was missed or the administer did not look, whereas the patient was already given with 2 doses in 2021.